Research PaperJournal of Pharmacology and PharmacotherapeuticsVol. 9 | Issue 2 | 2018 | pp. 104–108Open access
Adverse Drug Reactions at an Addiction Psychiatry Center: A Cross‑sectional Analysis
- 1*,
- 1,
- 2,
- 1,
- 2
- 1 Department of Psychiatry and NDDTC, All India Institute of Medical Sciences, New Delhi, India.
- 2 Pharmacovigilance Programme of India, Indian Pharmacopoeia Commission (IPC), Ghaziabad, Uttar Pradesh, India.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: Siddharth Sarkar
Department of Psychiatry and NDDTC, All India Institute of Medical Sciences, New Delhi, India.
Email: sidsarkar22@gmail.com
Copyright: © 2018 Manuscript Technomedia LLP. This is an open access article.
- Published:
- Jan 1, 2018
- Received:
- Mar 31, 2018
- Accepted:
- Jun 18, 2018
How to cite
Sarkar, S., Chadda, R. K., Thota, A., Dhagudu, N. K., & Prasad, T. (2018). Adverse Drug Reactions at an Addiction Psychiatry Center: A Cross‑sectional Analysis. Journal of Pharmacology and Pharmacotherapeutics, 9(2), 104–108. https://doi.org/10.4103/jpp.JPP_41_18
Abstract
Objective: To perform a cross sectional analysis of anticipated and unanticipated adverse drug reactions occurring at an addiction psychiatry center. Materials and Methods: This observational analysis presents data on the ADRs reported by the health‑care professionals at a tertiary care public‑funded treatment center. The types of ADRs encountered over a period of 12 months are presented along. Results: A total of 251 ADRs were encountered in patients with substance use disorders. Of them, 23% were unlabeled adverse reactions. At the center, tramadol was the most common medication implicated for ADR, followed by naltrexone and disulfiram. The most common adverse event reported was loss of appetite (n = 26). According to the system organ classification, gastrointestinal (18.7%) and psychiatric symptoms (18.7%) were the most common systems implicated. Conclusion: The current findings provide opportunities for sensitization of health‑care professionals. This will help in promoting safer drug use in the field of addiction psychiatry.
Keywords
Subject
Article metadata
| Title | Adverse Drug Reactions at an Addiction Psychiatry Center: A Cross‑sectional Analysis |
|---|---|
| Authors | Siddharth Sarkar; Rakesh K. Chadda; Anusha Thota; Naveen Kumar Dhagudu; Thota Prasad |
| Affiliations | Department of Psychiatry and NDDTC, All India Institute of Medical Sciences, New Delhi, India.; Pharmacovigilance Programme of India, Indian Pharmacopoeia Commission (IPC), Ghaziabad, Uttar Pradesh, India. |
| Corresponding author | sidsarkar22@gmail.com |
| Journal | Journal of Pharmacology and Pharmacotherapeutics |
| Volume / Issue | Vol. 9, Issue 2 (2018) |
Also in this issue
- Supplementary Protection Certificates are Detrimental to Medicine Affordabilitypp. 63–65
- Comprehensive Review on Methadone-Induced QT Prolongation and Torsadespp. 66–75
- Terlipressin-Induced Ischemic Complications: A Systematic Review of Published Case Reportspp. 76–85
- Frequency of Chemotherapy Medication Errors: A Systematic Reviewpp. 86–91
- Investigation of hERG1b Influence on hERG Channel Pharmacology at Physiological Temperaturepp. 92–103
Readers Also Viewed
Development and Validation of UV/visible Spectrophotometric Method for Estimation of Piroxicam from Bulk and Formulation
Sandip Mohan Honmane, Kunal Rajaram Yadav, Yuvraj Dilip Dange
Apr 23, 2025
Effects of Artificial Intelligence on Academic Performance of Library and Information Science University Students: A Meta-Analysis (2023-2025)
Kayode Sunday John Dada
Aug 6, 2026
Bridging Innovation and Impact: A Multidisciplinary Approach to Contemporary Research Challenges
Mueen Ahmed KK
Aug 11, 2026